Slilaty Steve N.
SEC CIK 1474684 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SBFM | Sunshine Biopharma Inc. | CEO, Dir, 10% | 130.0K | $12.0K | — | 3 | 2022-02-18 | 2024-03-04 |
Most active insiders at SBFM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NATAN DAVID | Dir | — | — |
Slilaty Steve N. made no open-market trades at SBFM in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-04 | SBFM | Sunshine Biopharma Inc. | Slilaty Steve N. | CEO, Dir, 10% | P - Purchase | $0.1 | +100.0K | 130.0K | +333% | +$10.0K | |
| 2024-02-12 | 2024-02-08 | SBFM | Sunshine Biopharma Inc. | Slilaty Steve N. | CEO, Dir, 10% | P - Purchase | $0.1 | +20.0K | 30.0K | +200% | +$2,000 | |
| 2022-02-22 | 2022-02-18 | SBFM | Sunshine Biopharma Inc. | Slilaty Steve N. | CEO, Dir | D - Sale to Iss | $0.1 | -990.0K | 10.0K | -99% | -$99.0K |
Purchase Sale Sale after option exercise All abbreviations